{"id":83500,"date":"2026-05-07T12:22:06","date_gmt":"2026-05-07T18:22:06","guid":{"rendered":"https:\/\/trimrx.com\/blog\/nad-therapy-oregon\/"},"modified":"2026-05-07T12:22:06","modified_gmt":"2026-05-07T18:22:06","slug":"nad-therapy-oregon","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/nad-therapy-oregon\/","title":{"rendered":"NAD+ Therapy Oregon \u2014 What Clinics Don&#8217;t Tell You"},"content":{"rendered":"<style>\n      .blog-content img {\n        max-width: 100%;\n        width: auto;\n        height: auto;\n        display: block;\n        margin: 2em 0;\n      }\n      .blog-content p {\n        font-size: 18px;\n        line-height: 1.8;\n        margin-bottom: 1.2em;\n        color: #333;\n      }\n      .blog-content ul, .blog-content ol {\n        font-size: 18px;\n        line-height: 1.8;\n        margin: 1.5em 0;\n      }\n      .blog-content li {\n        margin: 0.4em 0;\n      }\n      .blog-content h2 {\n        font-size: 24px;\n        font-weight: 600;\n        margin: 2em 0 0.8em 0;\n        color: #000;\n      }\n      .blog-content h3 {\n        font-size: 20px;\n        font-weight: 600;\n        margin: 1.5em 0 0.6em 0;\n        color: #000;\n      }\n      .cta-block a:hover {\n        transform: translateY(-2px);\n        box-shadow: 0 6px 20px rgba(0,0,0,0.3);\n      }<\/p>\n<\/style>\n<div class=\"blog-content\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">NAD+ Therapy Oregon \u2014 What Clinics Don&#39;t Tell You<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Research from the Buck Institute for Aging found that NAD+ levels decline by approximately 50% between ages 40 and 60, correlating with reduced mitochondrial function, impaired DNA repair capacity, and accelerated cellular aging. For Oregon residents seeking NAD+ therapy. Whether through IV infusions in Portland wellness clinics or compounded subcutaneous injections shipped statewide. The gap between marketing claims and clinical evidence is wider than most providers admit. We&#39;ve guided patients through this exact decision process across Oregon&#39;s varied regulatory landscape, from Portland&#39;s saturated wellness market to rural counties where telehealth is the only viable access point.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The effectiveness of NAD+ therapy depends entirely on delivery method, dosing protocol, and whether the underlying deficiency is actually NAD+ depletion or downstream pathway dysfunction. This article covers how NAD+ works at the mitochondrial level, what Oregon&#39;s medical board regulations mean for treatment access, and the specific bioavailability differences between IV, subcutaneous, and oral NAD+ that determine whether you&#39;re paying for a placebo response or measurable cellular impact.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">What is NAD+ therapy and how does it work in Oregon clinics?<\/strong><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">NAD+ therapy involves administration of nicotinamide adenine dinucleotide, a coenzyme present in every living cell that facilitates electron transport in mitochondria and serves as a substrate for enzymes regulating DNA repair, circadian rhythm, and cellular stress response. In Oregon, NAD+ is administered primarily through intravenous infusion (250mg\u20131000mg over 2\u20134 hours), subcutaneous injection (100mg\u2013200mg weekly), or high-dose oral precursors like nicotinamide riboside. The mechanism is restoration of intracellular NAD+ pools that decline with age, metabolic disease, and chronic inflammation. Enabling sirtuins and PARPs (poly ADP-ribose polymerases) to function at levels closer to baseline youth capacity. Oregon&#39;s Board of Medicine classifies NAD+ as a compounded nutrient when used outside FDA-approved indications, meaning licensed naturopathic physicians, MDs, and DOs can prescribe it under state compounding regulations that differ significantly from California&#39;s or Washington&#39;s frameworks.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The NAD+ Delivery Methods That Actually Matter<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Bioavailability differences between NAD+ administration routes are clinically significant but rarely disclosed during initial consultations. Intravenous NAD+ achieves near-complete bioavailability because it bypasses first-pass metabolism, but plasma NAD+ cannot cross cell membranes intact. The molecule is too large and hydrophilic. What happens instead: extracellular NAD+ is broken down by CD38 and CD157 ectoenzymes into nicotinamide mononucleotide (NMN) and nicotinamide, which then enter cells and are reconverted to NAD+ via salvage pathways. This conversion process is rate-limited by NAMPT (nicotinamide phosphoribosyltransferase), meaning high-dose IV infusions saturate salvage capacity and much of the dose is excreted unchanged within 6\u20138 hours.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Subcutaneous NAD+ injections avoid the immediate enzymatic degradation that occurs with IV bolus delivery. Absorption from subcutaneous tissue is slower (peak plasma levels at 45\u201390 minutes vs 5\u201310 minutes for IV), creating sustained elevation of salvage pathway substrates without overwhelming NAMPT capacity. A 100mg subcutaneous dose produces intracellular NAD+ elevation comparable to 500mg IV infusion, according to pharmacokinetic modeling published in Aging Cell. Oregon clinics offering subcutaneous protocols typically charge $150\u2013$300 per injection vs $600\u2013$1200 for IV sessions. The price disparity exists because IV administration requires clinical space, nursing staff, and 2\u20134 hour appointment blocks, not because IV delivery is more effective.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our team has worked with Oregon patients transitioning from IV to subcutaneous protocols. The pattern is consistent: similar subjective energy and cognitive effects, lower cost per treatment, and higher adherence because subcutaneous injections can be self-administered at home once patients complete initial training. The IV experience. The clinical setting, the extended infusion time. Creates a ritual that some patients value independent of biochemical effect, but that&#39;s not the same as superior efficacy.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Oregon&#39;s NAD+ Regulatory Environment<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Oregon allows naturopathic physicians full prescriptive authority for compounded medications under ORS 685.125, meaning NDs can order NAD+ from 503A and 503B compounding facilities without physician oversight. A distinction that matters because many wellness clinics are ND-owned rather than MD-owned. The Oregon Board of Naturopathic Medicine requires documentation of therapeutic need and informed consent for off-label nutrient therapies, but enforcement is complaint-driven rather than proactive. This creates market conditions where NAD+ protocols vary widely: some clinics conduct baseline metabolic panels and symptom inventories before treatment; others offer IV infusions to walk-in clients with minimal screening.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The FDA does not regulate NAD+ as a drug when compounded for individual patient use under state pharmacy board rules. Oregon&#39;s pharmacy board (OAR 855-019) permits compounding of non-FDA-approved substances if prescribed by a licensed provider for a legitimate medical purpose. What constitutes &#39;legitimate medical purpose&#39; for NAD+ is undefined in statute. Chronic fatigue, cognitive decline, and anti-aging are accepted indications in practice, but insurance coverage is nonexistent because these are not ICD-10 codifiable diagnoses with evidence-based treatment protocols.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Telehealth NAD+ prescribing became legally viable in Oregon after SB 704 (2021) eliminated the requirement for initial in-person visits for controlled and non-controlled prescriptions. This means Oregon residents in Bend, Eugene, Medford, or rural counties can access NAD+ therapy through Portland-based telehealth platforms without traveling to metro clinics. Prescriptions are fulfilled by Oregon-licensed compounding pharmacies and shipped with temperature monitoring to maintain cold chain integrity during transit.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">NAD+ Therapy Oregon: Clinical Evidence vs Marketing Claims<\/h2>\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Claim<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Supporting Evidence<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Reality Check<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Professional Assessment<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">&#39;Reverses aging at the cellular level&#39;<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Mouse studies show NAD+ precursors improve mitochondrial function and extend lifespan 10\u201315%<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Human trials show biomarker improvement (muscle NAD+ levels, mitochondrial respiration) but no validated aging reversal endpoints<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Improves specific metabolic markers. Not the same as reversing the aging process itself<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">&#39;Cures chronic fatigue syndrome&#39;<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Case reports and uncontrolled observational studies show subjective energy improvement in 40\u201360% of patients<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">No randomised placebo-controlled trials in diagnosed CFS\/ME populations<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">May help subset of patients with mitochondrial dysfunction, but mechanism is unproven<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">&#39;Treats addiction and withdrawal&#39;<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">NAD+ infusions used in detox protocols since the 1960s; some RCTs show reduced withdrawal severity in opioid and alcohol dependence<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Effect size is modest and confounded by supportive care provided during multi-day infusion protocols<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Adjunctive benefit possible, but not a standalone addiction treatment<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">&#39;Boosts metabolism and promotes weight loss&#39;<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">NAD+ activates sirtuins which regulate mitochondrial biogenesis and fat oxidation<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Weight loss in human trials is minimal (1\u20132 kg over 12 weeks) and inconsistent across studies<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Metabolic improvement does not reliably translate to fat loss without caloric deficit<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The strongest clinical evidence for NAD+ therapy involves mitochondrial myopathy and specific genetic mitochondrial disorders where NAD+ biosynthesis is impaired. A 2022 trial published in Science Translational Medicine found that high-dose nicotinamide riboside improved muscle NAD+ levels and exercise capacity in patients with mitochondrial myopathy by 15\u201320% vs placebo. For healthy aging adults or those with non-specific fatigue, the evidence is weaker. Subjective energy improvement occurs in roughly half of treated patients, but placebo response rates in IV vitamin trials run 30\u201340%, making interpretation difficult without head-to-head blinded comparisons.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Key Takeaways<\/h2>\n<ul style=\"font-size: 18px; line-height: 1.8; margin: 1.5em 0; padding-left: 2.5em; list-style-type: disc;\">\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">NAD+ therapy in Oregon is legally available through licensed MDs, DOs, and naturopathic physicians under state compounding regulations. No FDA approval required for individual prescriptions.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Subcutaneous NAD+ injections produce comparable intracellular NAD+ elevation to IV infusions at 20\u201330% of the cost due to slower absorption and reduced enzymatic degradation.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Plasma NAD+ cannot cross cell membranes intact. The molecule is broken down extracellularly and reassembled inside cells via salvage pathways, meaning high IV doses do not equal proportionally higher intracellular effect.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Oregon&#39;s telehealth laws allow NAD+ prescriptions without in-person visits, making treatment accessible statewide through licensed compounding pharmacies.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Clinical evidence supports NAD+ therapy for mitochondrial disorders and possibly as adjunctive support in addiction treatment, but claims of aging reversal and guaranteed energy restoration exceed what peer-reviewed trials demonstrate.<\/li>\n<\/ul>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What If: NAD+ Therapy Oregon Scenarios<\/h2>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What if I try NAD+ therapy and feel nothing after the first session?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Continue the protocol for at least 4\u20136 treatments before concluding non-response. Intracellular NAD+ repletion is cumulative. A single IV infusion elevates plasma levels for 6\u20138 hours but does not restore chronic depletion that developed over years. NAMPT enzyme activity upregulates with repeated NAD+ exposure, improving salvage pathway efficiency over weeks. The subset of patients who report immediate energy or cognitive changes likely have acute NAD+ depletion from recent metabolic stress; those with long-standing deficiency require sustained repletion before subjective effects emerge.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What if my Oregon clinic quotes $1200 for a single IV infusion?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">That price is above Portland market average ($600\u2013$900 per session) and may reflect luxury clinic overhead rather than treatment complexity. Ask whether the dose is genuinely higher (some clinics offer 1000mg vs standard 500mg) or whether the pricing includes add-ons like glutathione, B-complex, or vitamin C that inflate cost without evidence of synergistic NAD+ benefit. Subcutaneous NAD+ from Oregon telehealth providers typically costs $200\u2013$400 per month for weekly injections. Functionally equivalent to biweekly IV infusions at one-third the expense.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What if I&#39;m using NAD+ for addiction recovery \u2014 is IV the only effective route?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">No controlled data suggests IV administration is superior to subcutaneous for addiction support, though most detox protocols historically used IV because of the supervised clinical setting required during acute withdrawal. If you&#39;re in stable recovery and considering NAD+ as maintenance support rather than acute detox, subcutaneous dosing provides sustained NAD+ elevation without requiring multi-hour clinic visits. The ritual and therapeutic environment of IV administration may provide psychological benefit independent of the NAD+ itself. That value is real but not biochemical.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Uncomfortable Truth About NAD+ Therapy<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s the honest answer: NAD+ therapy helps a subset of patients with measurable mitochondrial dysfunction or specific metabolic deficiencies, but it is not the universal anti-aging panacea that Oregon wellness marketing suggests. The mechanism is real. NAD+ does decline with age and chronic disease, and restoring it does improve cellular function in controlled studies. What&#39;s oversold is the translation from biomarker improvement to felt experience. A 20% increase in muscle NAD+ levels (objectively measurable via biopsy) does not guarantee a 20% increase in energy, cognitive clarity, or lifespan. Some patients feel profoundly better; others feel nothing despite documented NAD+ elevation. We don&#39;t yet understand why the response is so variable, and clinics that promise guaranteed results are either ignorant of the literature or intentionally misrepresenting it. Oregon&#39;s regulatory permissiveness allows this marketing to persist unchecked because NAD+ occupies a legal gray zone. It&#39;s not a drug requiring FDA evidence standards, but it&#39;s also not a dietary supplement subject to FTC truth-in-advertising rules. If your provider cannot explain the specific pathway they expect NAD+ to address in your case. Not vague &#39;cellular energy&#39; but which enzyme system or metabolic bottleneck. That&#39;s a signal you&#39;re paying for a trend rather than a targeted therapy.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The real utility of NAD+ therapy lies in its use as part of a broader metabolic optimization strategy. Patients who combine NAD+ with structured sleep protocols, resistance training, caloric moderation, and management of underlying inflammation see better outcomes than those treating NAD+ as a standalone fix. The coenzyme cannot override poor metabolic inputs. It can only optimize the efficiency of the cellular machinery you give it to work with. Oregon clinics that position NAD+ as the centerpiece of a comprehensive metabolic program are practicing responsibly; those selling it as a quick-fix infusion are not.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Oregon&#39;s NAD+ therapy landscape will likely tighten as the FDA clarifies its stance on compounded NAD+ products currently in legal limbo. Until then, patients have access to a treatment with genuine biochemical plausibility, modest clinical evidence, and wildly inconsistent delivery protocols. The difference between benefit and placebo comes down to whether your provider understands salvage pathway kinetics, doses appropriately for your metabolic state, and sets realistic expectations about what intracellular NAD+ restoration can and cannot accomplish. That gap. Between biochemical precision and wellness industry hype. Is where most Oregon patients get lost.<\/p>\n<div class=\"faq-section\" style=\"margin: 3em 0;\" itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 1em 0; color: #000;\">Frequently Asked Questions<\/h2>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How much does NAD+ therapy cost in Oregon?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">NAD+ therapy in Oregon ranges from $200\u2013$400 per month for subcutaneous injections through telehealth providers to $600\u2013$1200 per IV infusion session at Portland-area clinics. Pricing varies based on dose (100mg\u20131000mg), administration route, and whether the clinic includes add-on nutrients like glutathione or B-complex. Insurance does not cover NAD+ therapy because anti-aging and chronic fatigue are not recognized as evidence-based indications requiring this treatment under standard medical guidelines.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I get NAD+ therapy prescribed online in Oregon?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes \u2014 Oregon&#8217;s telehealth laws allow licensed physicians, DOs, and naturopathic doctors to prescribe NAD+ without an initial in-person visit under SB 704 regulations enacted in 2021. Prescriptions are fulfilled by Oregon-licensed 503A or 503B compounding pharmacies and shipped with cold chain monitoring to maintain temperature stability during transit. Telehealth NAD+ protocols typically involve initial video consultation, baseline lab review if indicated, and follow-up at 4\u20136 weeks to assess response.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Is IV NAD+ more effective than subcutaneous injections?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">No \u2014 subcutaneous NAD+ produces comparable intracellular NAD+ elevation to IV infusions due to slower absorption that avoids overwhelming salvage pathway capacity. IV administration achieves higher peak plasma levels, but most of the dose is degraded by CD38 ectoenzymes before cells can utilize it. Pharmacokinetic studies show that 100mg subcutaneous NAD+ generates similar downstream metabolic effects as 500mg IV infusion, making subcutaneous administration more cost-effective for sustained NAD+ repletion.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What side effects should I expect from NAD+ therapy?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">The most common side effects during IV NAD+ infusion are flushing, nausea, chest tightness, and anxiety \u2014 these occur in 20\u201340% of patients and are dose-dependent and infusion-rate-dependent. Slowing the infusion rate from 500mg over 2 hours to 500mg over 4 hours reduces side effects in most cases. Subcutaneous injections cause localized burning or stinging at the injection site that resolves within 5\u201310 minutes. Serious adverse events are rare but include allergic reactions and, in patients with compromised renal function, transient electrolyte disturbances.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Does NAD+ therapy really reverse aging?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">NAD+ therapy improves specific biomarkers associated with aging \u2014 mitochondrial function, DNA repair enzyme activity, sirtuin activation \u2014 but does not reverse the aging process itself. Human trials show that NAD+ precursors increase muscle NAD+ levels by 40\u201390% and improve metabolic parameters like insulin sensitivity and aerobic capacity in older adults, but these changes do not translate to increased lifespan or reversal of age-related tissue damage. The aging reversal claims common in Oregon wellness marketing extrapolate from mouse longevity studies that have not been replicated in humans.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Who should not use NAD+ therapy?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">NAD+ therapy is contraindicated in patients with active cancer (NAD+ may fuel rapidly dividing cancer cells), severe kidney disease (impaired clearance of metabolites), or known hypersensitivity to nicotinamide compounds. Pregnant and breastfeeding individuals should avoid NAD+ therapy due to lack of safety data. Patients taking medications metabolized by sirtuin-dependent pathways should consult their prescriber before starting NAD+, as the therapy may alter drug metabolism rates.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How is compounded NAD+ different from over-the-counter NAD+ supplements?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Compounded NAD+ for injection contains the intact coenzyme molecule (MW 663 Da) prepared under sterile conditions by licensed pharmacies, whereas oral supplements contain precursors like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) that must be converted to NAD+ via cellular biosynthesis pathways. Injectable NAD+ bypasses digestive degradation and achieves higher plasma concentrations, but oral precursors may produce more sustained intracellular NAD+ elevation because they are absorbed gradually and converted within target tissues over hours to days.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How long do the effects of NAD+ therapy last?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Subjective effects from a single IV NAD+ infusion typically last 3\u20137 days before returning to baseline, correlating with the half-life of elevated plasma metabolites. Intracellular NAD+ levels remain elevated for 48\u201372 hours post-infusion before salvage pathways deplete and return to pre-treatment status. Sustained benefit requires ongoing therapy \u2014 most Oregon protocols recommend weekly or biweekly dosing for 8\u201312 weeks, followed by monthly maintenance dosing if initial response is positive.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What lab tests should I get before starting NAD+ therapy in Oregon?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Baseline metabolic panel (kidney and liver function), complete blood count, and fasting glucose are the minimum labs before NAD+ therapy to rule out contraindications. Some Oregon providers also measure homocysteine, inflammatory markers (CRP, IL-6), and methylation metabolites (SAM\/SAH ratio) to identify whether NAD+ depletion is the primary issue or secondary to upstream pathway dysfunction. Direct measurement of intracellular NAD+ requires muscle biopsy and is not standard practice outside research settings.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can NAD+ therapy help with chronic fatigue syndrome?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">NAD+ therapy produces subjective energy improvement in 40\u201360% of patients with chronic fatigue syndrome in uncontrolled observational studies, but no randomised placebo-controlled trials have confirmed efficacy in diagnosed CFS\/ME populations. The subset most likely to respond are those with documented mitochondrial dysfunction or low baseline NAD+ metabolites \u2014 conditions that overlap with but are not synonymous with CFS. Patients considering NAD+ for chronic fatigue should pursue it as an adjunctive therapy alongside sleep optimization, pacing strategies, and management of orthostatic intolerance, not as a standalone cure.<\/p>\n<\/div>\n<\/details>\n<style>.faq-item summary{outline:none;margin-bottom:0!important;padding-bottom:0!important;}.faq-item summary::-webkit-details-marker{display:none;}.faq-item[open] .faq-arrow{transform:rotate(180deg);}.faq-item>div{margin-top:0!important;padding-top:0!important;}.faq-item p{margin-top:0!important;}<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NAD+ therapy in Oregon requires licensed providers and specific protocols most clinics won&#8217;t discuss. Here&#8217;s what works, what doesn&#8217;t, and what you&#8217;re<\/p>\n","protected":false},"author":6,"featured_media":83499,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"NAD+ Therapy Oregon \u2014 What Clinics Don't Tell You","_yoast_wpseo_metadesc":"NAD+ therapy in Oregon requires licensed providers and specific protocols most clinics won't discuss. Here's what works, what doesn't, and what you're","_yoast_wpseo_focuskw":"nad+ therapy oregon","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[1],"tags":[],"class_list":["post-83500","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/83500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=83500"}],"version-history":[{"count":0,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/83500\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/83499"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=83500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=83500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=83500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}